Publications by authors named "Danny N Khalil"

18Publications

Immune checkpoint inhibitors for hepatocellular carcinoma.

Cancer 2019 Oct 10;125(19):3312-3319. Epub 2019 Jul 10.

Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article and Find Full Text PDF
October 2019

Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect.

Front Immunol 2019 2;10:604. Epub 2019 Apr 2.

Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

View Article and Find Full Text PDF
July 2020

Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?

Dig Dis Sci 2019 04;64(4):918-927

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA.

View Article and Find Full Text PDF
April 2019

Classification of Pancreatic Cancer: Ready for Practical Application?

Clin Cancer Res 2018 09 11;24(18):4355-4356. Epub 2018 May 11.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article and Find Full Text PDF
September 2018

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

Nat Rev Clin Oncol 2016 May 15;13(5):273-90. Epub 2016 Mar 15.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.

View Article and Find Full Text PDF
May 2016

The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.

Adv Cancer Res 2015 9;128:1-68. Epub 2015 Jun 9.

Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address:

View Article and Find Full Text PDF
April 2016

Treatments for noncutaneous melanoma.

Hematol Oncol Clin North Am 2014 Jun;28(3):507-21

Developmental Therapeutics, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, No. 1071, New York, NY 10065, USA. Electronic address:

View Article and Find Full Text PDF
June 2014

Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?

Breast Cancer Res Treat 2012 Aug 22;134(3):1125-32. Epub 2012 Jun 22.

Winthrop-University Hospital Campus of SUNY Health Sciences Center at Stony Brook, 200 Old Country Rd, Room #450, Mineola, NY 11501, USA.

View Article and Find Full Text PDF
August 2012